NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 70 filers reported holding NEWLINK GENETICS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 1,500 | -21.1% | 0.00% | – |
| Q4 2018 | $2,000 | -50.0% | 1,900 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -89.2% | 1,900 | -89.4% | 0.00% | -100.0% |
| Q2 2018 | $37,000 | -57.0% | 17,900 | +41.0% | 0.00% | -57.1% |
| Q1 2018 | $86,000 | -35.3% | 12,699 | -71.2% | 0.01% | +16.7% |
| Q4 2017 | $133,000 | -18.9% | 44,099 | -67.4% | 0.01% | 0.0% |
| Q3 2017 | $164,000 | -33.1% | 135,083 | +58.4% | 0.01% | -33.3% |
| Q2 2017 | $245,000 | -69.7% | 85,292 | -7.9% | 0.01% | -72.7% |
| Q1 2017 | $809,000 | +100.2% | 92,600 | -25.9% | 0.03% | +120.0% |
| Q4 2016 | $404,000 | -46.4% | 124,941 | -20.7% | 0.02% | -55.9% |
| Q3 2016 | $754,000 | -17.9% | 157,494 | -16.6% | 0.03% | -27.7% |
| Q2 2016 | $918,000 | -50.8% | 188,794 | -15.7% | 0.05% | -61.5% |
| Q1 2016 | $1,866,000 | -15.8% | 223,952 | +4.8% | 0.12% | -1.6% |
| Q4 2015 | $2,217,000 | – | 213,600 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |